205 related articles for article (PubMed ID: 12578823)
1. p19Arf-p53 tumor suppressor pathway regulates cell motility by suppression of phosphoinositide 3-kinase and Rac1 GTPase activities.
Guo F; Gao Y; Wang L; Zheng Y
J Biol Chem; 2003 Apr; 278(16):14414-9. PubMed ID: 12578823
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Rho family GTPases in p19Arf- and p53-mediated proliferation of primary mouse embryonic fibroblasts.
Guo F; Zheng Y
Mol Cell Biol; 2004 Feb; 24(3):1426-38. PubMed ID: 14729984
[TBL] [Abstract][Full Text] [Related]
3. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion.
Guo F; Zheng Y
Oncogene; 2004 Jul; 23(33):5577-85. PubMed ID: 15122327
[TBL] [Abstract][Full Text] [Related]
4. p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
Kelly-Spratt KS; Gurley KE; Yasui Y; Kemp CJ
PLoS Biol; 2004 Aug; 2(8):E242. PubMed ID: 15314658
[TBL] [Abstract][Full Text] [Related]
5. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
[TBL] [Abstract][Full Text] [Related]
6. Multiple domains of the mouse p19ARF tumor suppressor are involved in p53-independent apoptosis.
Matsuoka M; Kurita M; Sudo H; Mizumoto K; Nishimoto I; Ogata E
Biochem Biophys Res Commun; 2003 Feb; 301(4):1000-10. PubMed ID: 12589812
[TBL] [Abstract][Full Text] [Related]
7. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
[TBL] [Abstract][Full Text] [Related]
8. Differential p53-independent outcomes of p19(Arf) loss in oncogenesis.
Chen Z; Carracedo A; Lin HK; Koutcher JA; Behrendt N; Egia A; Alimonti A; Carver BS; Gerald W; Teruya-Feldstein J; Loda M; Pandolfi PP
Sci Signal; 2009 Aug; 2(84):ra44. PubMed ID: 19690330
[TBL] [Abstract][Full Text] [Related]
9. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
[TBL] [Abstract][Full Text] [Related]
10. CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53.
Hasan MK; Yaguchi T; Sugihara T; Kumar PK; Taira K; Reddel RR; Kaul SC; Wadhwa R
J Biol Chem; 2002 Oct; 277(40):37765-70. PubMed ID: 12154087
[TBL] [Abstract][Full Text] [Related]
11. p19ARF-induced p53-independent apoptosis largely occurs through BAX.
Suzuki H; Kurita M; Mizumoto K; Nishimoto I; Ogata E; Matsuoka M
Biochem Biophys Res Commun; 2003 Dec; 312(4):1273-7. PubMed ID: 14652011
[TBL] [Abstract][Full Text] [Related]
12. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
13. p53-independent apoptosis is induced by the p19ARF tumor suppressor.
Tsuji K; Mizumoto K; Sudo H; Kouyama K; Ogata E; Matsuoka M
Biochem Biophys Res Commun; 2002 Jul; 295(3):621-9. PubMed ID: 12099684
[TBL] [Abstract][Full Text] [Related]
14. Arf induces p53-dependent and -independent antiproliferative genes.
Kuo ML; Duncavage EJ; Mathew R; den Besten W; Pei D; Naeve D; Yamamoto T; Cheng C; Sherr CJ; Roussel MF
Cancer Res; 2003 Mar; 63(5):1046-53. PubMed ID: 12615721
[TBL] [Abstract][Full Text] [Related]
15. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
[TBL] [Abstract][Full Text] [Related]
16. Mdm2 regulates p53 independently of p19(ARF) in homeostatic tissues.
O'Leary KA; Mendrysa SM; Vaccaro A; Perry ME
Mol Cell Biol; 2004 Jan; 24(1):186-91. PubMed ID: 14673154
[TBL] [Abstract][Full Text] [Related]
17. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
Aslanian A; Iaquinta PJ; Verona R; Lees JA
Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
[TBL] [Abstract][Full Text] [Related]
19. Arf tumor suppressor promoter monitors latent oncogenic signals in vivo.
Zindy F; Williams RT; Baudino TA; Rehg JE; Skapek SX; Cleveland JL; Roussel MF; Sherr CJ
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15930-5. PubMed ID: 14665695
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor p53 and its homologue p73alpha affect cell migration.
Sablina AA; Chumakov PM; Kopnin BP
J Biol Chem; 2003 Jul; 278(30):27362-71. PubMed ID: 12750388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]